UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial

The Lancet (British edition), 2022-01, Vol.399 (10321), p.237-248

2022

Volltextzugriff (PDF)

Commentary: Long-Term Changes of Inflammatory Biomarkers in Individuals on Suppressive Three-Drug or Two-Drug Antiretroviral Regimens

Frontiers in immunology, 2022-04, Vol.13, p.904689-904689

2022

Volltextzugriff (PDF)

Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial

The Lancet (British edition), 2011-07, Vol.378 (9787), p.238-246

2011

Volltextzugriff (PDF)

Clinical challenges in HIV/AIDS: Hints for advancing prevention and patient management strategies

Advanced drug delivery reviews, 2016-08, Vol.103, p.5-19

2016

Volltextzugriff (PDF)

Dual Therapy Treatment Strategies for the Management of Patients Infected with HIV: A Systematic Review of Current Evidence in ARV-Naive or ARV-Experienced, Virologically Suppressed Patients

PloS one, 2016-02, Vol.11 (2), p.e0148231

2016

Volltextzugriff (PDF)

Latin America Priorities after 40 years of the beginning of the HIV pandemic

Lancet Regional Health - Americas (Online), 2021-09, Vol.1, p.100024-100024, Article 100024

2021

Volltextzugriff (PDF)

Dual therapy with lopinavir and ritonavir plus lamivudine versus triple therapy with lopinavir and ritonavir plus two nucleoside reverse transcriptase inhibitors in antiretroviral-therapy-naive adults with HIV-1 infection: 48 week results of the randomised, open label, non-inferiority GARDEL trial

The Lancet infectious diseases, 2014-07, Vol.14 (7), p.572-580

2014

Volltextzugriff (PDF)

Retention among transgender women treated with dolutegravir associated with tenofovir/lamivudine or emtricitabine in Argentina: TransViiV study

PloS one, 2023-01, Vol.18 (1), p.e0279996

2023

Volltextzugriff (PDF)

Efficacy and safety of switching to dolutegravir/lamivudine in virologically suppressed people with HIV-1 aged ≥ 50 years: week 48 pooled results from the TANGO and SALSA studies

AIDS research and therapy, 2024-03, Vol.21 (1), p.17-9, Article 17

2024

Volltextzugriff (PDF)

The HIV care continuum in Latin America: challenges and opportunities

The Lancet infectious diseases, 2015-07, Vol.15 (7), p.833-839

2015

Volltextzugriff (PDF)

Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2007-07, Vol.370 (9581), p.29-38

2007

Volltextzugriff (PDF)

Changes in Inflammatory and Atherogenesis Biomarkers With the 2-Drug Regimen Dolutegravir Plus Lamivudine in Antiretroviral Therapy–Experienced, Virologically Suppressed People With HIV-1: A Systematic Literature Review

Open forum infectious diseases, 2022-04, Vol.9 (4), p.ofac068-ofac068

2022

Volltextzugriff (PDF)

Effectiveness of protease inhibitor monotherapy versus combination antiretroviral maintenance therapy: a meta-analysis

PloS one, 2011-07, Vol.6 (7), p.e22003-e22003

2011

Volltextzugriff (PDF)

Prevalence of cryptococcal infection among advanced HIV patients in Argentina using lateral flow immunoassay

PloS one, 2017-06, Vol.12 (6), p.e0178721-e0178721

2017

Volltextzugriff (PDF)

Home-based HIV testing: Using different strategies among transgender women in Argentina

PloS one, 2020, Vol.15 (3), p.e0230429-e0230429

2020

Volltextzugriff (PDF)

Preference for long-acting injectable for ART and PrEP among people with and without HIV: a cross-sectional study in Argentina

Therapeutic advances in infectious disease, 2024-01, Vol.11

2024

Volltextzugriff (PDF)

Identifying the needs of older people living with HIV (≥ 50 years old) from multiple centres over the world: a descriptive analysis

AIDS research and therapy, 2023-02, Vol.20 (1), p.10-10, Article 10

2023

Volltextzugriff (PDF)

High diversity of human polyomaviruses in environmental and clinical samples in Argentina: Detection of JC, BK, Merkel-cell, Malawi, and human 6 and 7 polyomaviruses

The Science of the total environment, 2016-01, Vol.542 (Pt A), p.192-202

2016

Volltextzugriff (PDF)

Late-onset opportunistic infections while receiving anti-retroviral therapy in Latin America: burden and risk factors

International journal of infectious diseases, 2022-09, Vol.122, p.469-475

2022

Volltextzugriff (PDF)

Inflammatory biomarker levels over 48 weeks with dual vs triple lopinavir/ritonavir-based therapy: Substudy of a randomized trial

PloS one, 2019-09, Vol.14 (9), p.e0221653-e0221653

2019

Volltextzugriff (PDF)

RBD-specific polyclonal F(ab´)2 fragments of equine antibodies in patients with moderate to severe COVID-19 disease: A randomized, multicenter, double-blind, placebo-controlled, adaptive phase 2/3 clinical trial

EClinicalMedicine, 2021-04, Vol.34, p.100843-100843, Article 100843

2021

Volltextzugriff (PDF)

Unity is strength: creation and future actions for a consortium for HIV cure research in Latin America and the Caribbean 'Lac-Cura'

HIV research & clinical practice, 2024-12, Vol.25 (1), p.2403955

2024

Volltextzugriff (PDF)

Early skewed distribution of total and HIV-specific CD8+ T-cell memory phenotypes during primary HIV infection is related to reduced antiviral activity and faster disease progression

PloS one, 2014-08, Vol.9 (8), p.e104235-e104235

2014

Volltextzugriff (PDF)

Candidates for inclusion in a universal antiretroviral regimen: dolutegravir

Current opinion in HIV & AIDS, 2017-07, Vol.12 (4), p.318-323

Cahn, Pedro

2017

Volltextzugriff (PDF)

1 – 25 von 294

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(256)
Mit Volltextzugriff
(221)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(198)
Science & Technology
(196)
Life Sciences & Biomedicine
(172)
Infectious Diseases
(129)
Hiv
(127)
Hiv Infections - Drug Therapy
(125)
Female
(120)
Human Immunodeficiency Virus
(118)
Adult
(114)
Male
(110)
Immunology
(78)
Biological And Medical Sciences
(65)
Antiretroviral Drugs
(64)
Medical Sciences
(63)
Middle Aged
(62)
Aids/hiv
(61)
Anti-Hiv Agents - Therapeutic Use
(58)
Aids
(57)
Acquired Immune Deficiency Syndrome
(53)
Antiviral Agents
(49)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial

Commentary: Long-Term Changes of Inflammatory Biomarkers in Individuals on Suppressive Three-Drug or Two-Drug Antiretroviral Regimens

Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial

Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study

Clinical challenges in HIV/AIDS: Hints for advancing prevention and patient management strategies

Dual Therapy Treatment Strategies for the Management of Patients Infected with HIV: A Systematic Review of Current Evidence in ARV-Naive or ARV-Experienced, Virologically Suppressed Patients

Latin America Priorities after 40 years of the beginning of the HIV pandemic

Dual therapy with lopinavir and ritonavir plus lamivudine versus triple therapy with lopinavir and ritonavir plus two nucleoside reverse transcriptase inhibitors in antiretroviral-therapy-naive adults with HIV-1 infection: 48 week results of the randomised, open label, non-inferiority GARDEL trial

Retention among transgender women treated with dolutegravir associated with tenofovir/lamivudine or emtricitabine in Argentina: TransViiV study

Efficacy and safety of switching to dolutegravir/lamivudine in virologically suppressed people with HIV-1 aged ≥ 50 years: week 48 pooled results from the TANGO and SALSA studies

The HIV care continuum in Latin America: challenges and opportunities

Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial

Changes in Inflammatory and Atherogenesis Biomarkers With the 2-Drug Regimen Dolutegravir Plus Lamivudine in Antiretroviral Therapy–Experienced, Virologically Suppressed People With HIV-1: A Systematic Literature Review

Effectiveness of protease inhibitor monotherapy versus combination antiretroviral maintenance therapy: a meta-analysis

Prevalence of cryptococcal infection among advanced HIV patients in Argentina using lateral flow immunoassay

Home-based HIV testing: Using different strategies among transgender women in Argentina

Preference for long-acting injectable for ART and PrEP among people with and without HIV: a cross-sectional study in Argentina

Identifying the needs of older people living with HIV (≥ 50 years old) from multiple centres over the world: a descriptive analysis

High diversity of human polyomaviruses in environmental and clinical samples in Argentina: Detection of JC, BK, Merkel-cell, Malawi, and human 6 and 7 polyomaviruses

Late-onset opportunistic infections while receiving anti-retroviral therapy in Latin America: burden and risk factors

Inflammatory biomarker levels over 48 weeks with dual vs triple lopinavir/ritonavir-based therapy: Substudy of a randomized trial

RBD-specific polyclonal F(ab´)2 fragments of equine antibodies in patients with moderate to severe COVID-19 disease: A randomized, multicenter, double-blind, placebo-controlled, adaptive phase 2/3 clinical trial

Unity is strength: creation and future actions for a consortium for HIV cure research in Latin America and the Caribbean 'Lac-Cura'

Early skewed distribution of total and HIV-specific CD8+ T-cell memory phenotypes during primary HIV infection is related to reduced antiviral activity and faster disease progression

Candidates for inclusion in a universal antiretroviral regimen: dolutegravir

Suchergebnisse filtern